Explore our comprehensive coverage of psychedelics, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The global behavioral health market faces a structural crisis driven by severe psychiatric workforce shortages, unregulated AI mental health chatbots,...
Read Full Story →
WorldThe FDA has granted full approval for Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depr...
HealthThe FDA has approved MDMA-assisted psychotherapy for severe PTSD based on Phase 3 MAPS trial data. T...
Mental HealthThe NHS has officially integrated MDMA and psilocybin-assisted therapies into its standard formulary...
